SCHEMBL5370037

SCHEMBL5370037

OB(Oc1ccc(Br)cc1)Oc1ccc(COCc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.48
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ FFAR1 O14842 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ APP P05067 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ MRGPRX4 Q96LA9 1/20 0.39
▸ MAOB P27338 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373560 0.85 TSHR (0.50) TSHRFFAR1LMNACYP1A2PTGS1
SCHEMBL6662818 0.84 TSHR (0.58) TSHRFFAR1FFAR4POLBLMNA
SCHEMBL5377522 0.84 TSHR (0.48) TSHRAPPLMNACYP1A2PTGS1
SCHEMBL2657770 0.82 TSHR (0.71) TSHRRXRARXRBAPPLMNA
SCHEMBL5373718 0.80 TSHR (0.44) TSHRRXRARXRBLMNACYP1A2
SCHEMBL14503428 0.80 TSHR (0.52) TSHRRXRARXRBMAOBAR
SCHEMBL8486861 0.77 TSHR (0.62) TSHRPOLBLMNACYP1A2PTGS1
SCHEMBL4768252 0.77 TSHR (0.61) TSHRAPPMAOBIDO1
Bromobenzene SCHEMBL17868575 0.76 TSHR (0.75) TSHRPOLBMAOBIDO1
SCHEMBL5368711 0.76 DRD2 (0.40) TSHRFFAR1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 — — US claimed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 — — EP claimed
US-7217701-B2 Intracellular calcium concentration increase inhibitors KATSUHIKO MIKOSHIBA (JP) 2007-05-15 — — US disclosed
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 — — US disclosed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors CAB39, BPGM, ORAI1 TSHR 3019/4885RXRA 4671/4885RXRB 4507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback